Results for “ ”

Entry Author Date Location
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More 08/26/16 National
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
In Wake Of Infamous Biotech Party, 20 Women Join New Exec Training 08/23/16 National
Amylyx Nabs $5M to Take Aim at Nerve Cell Death in ALS Patients 08/22/16 Boston
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
In Cholesterol Drug Price Fight, Real Message Is “Wait Til Next Year” 08/18/16 National
Cerulean’s Shares Routed as Cancer Drug Comes up Short Again 08/17/16 Boston
CRISPR and More at Boston’s Life Science Disruptors Oct. 20 08/17/16 Boston
Rare Drug Developer Chiasma Lays Off More Workers After FDA Impasse 08/16/16 Boston
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
As U.S. Looks to Launch Precision Health Study, Google’s Role Emerges 08/11/16 National
Aldeyra Surges on New Data, Another Step For Inflammation Drug 08/09/16 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
At Alzheimer’s Meeting, Firms Take Page From Silver Linings Playbook 07/29/16 National
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
After Zafgen Abandons Prader-Willi Drug, Could Rhythm Offer Hope? 07/28/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble 07/26/16 Boston
Tobira Fails Main Goal in NASH Study, But Forges Ahead To Next Trial 07/25/16 San Francisco
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Indigo’s Microbial Tech for Crops Lands $100M to Fight Plant Stresses 07/21/16 Boston
Page 2 of 113 « previous page · next page »